GlassScriptPhysician profile
George T Rowe
NPI 1770511644
$101.77
in general payments reported to CMS, 2019-2025
7 companies · none reported in 2025
See the full distribution for Adolescent Medicine (Pediatrics)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $102.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kaleo, INC. | $19.19 | 2019 | |
| Pfizer INC. | $18.50 | 2019 | |
| Vertical Pharmaceuticals, LLC | $17.74 | 2019 | |
| Neos Therapeutics, LP | $17.29 | 2019 | |
| Phadia US INC. | $17.10 | 2019 | |
| Genentech USA, INC. | $11.95 | 2019 |
1 company reported research payments only; those appear in the research section below.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw George Rowe listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.